Lazard Asset Management’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-9,176
| Closed | -$217K | – | 2542 |
|
|
2023
Q3 | $217K | Buy |
9,176
+877
| +11% | +$16.5K | ﹤0.01% | 1364 |
|
|
2023
Q2 | $134K | Sell |
8,299
-687,755
| -99% | -$11.4M | ﹤0.01% | 1469 |
|
|
2023
Q1 | $12.1M | Sell |
696,054
-65,703
| -9% | -$1.18M | 0.02% | 543 |
|
|
2022
Q4 | $14.3M | Sell |
761,757
-304,202
| -29% | -$5.86M | 0.02% | 498 |
|
|
2022
Q3 | $18.9M | Buy |
1,065,959
+1,055,643
| +10,233% | +$18.3M | 0.03% | 424 |
|
|
2022
Q2 | $179K | Sell |
10,316
-14,407
| -58% | -$275K | ﹤0.01% | 1314 |
|
|
2022
Q1 | $516K | Buy |
24,723
+19,492
| +373% | +$373K | ﹤0.01% | 1104 |
|
|
2021
Q4 | $93K | Buy |
5,231
+2,097
| +67% | +$33.7K | ﹤0.01% | 1471 |
|
|
2021
Q3 | $44K | Buy |
3,134
+1,302
| +71% | +$20.3K | ﹤0.01% | 1742 |
|
|
2021
Q2 | $30K | Buy |
+1,832
| New | +$32.8K | ﹤0.01% | 1774 |
|
|
2021
Q1 | – | Sell |
-5,128
| Closed | -$93K | – | 2074 |
|
|
2020
Q4 | $93K | Sell |
5,128
-542
| -10% | -$8.6K | ﹤0.01% | 1203 |
|
|
2020
Q3 | $72K | Sell |
5,670
-890
| -14% | -$11.4K | ﹤0.01% | 1088 |
|
|
2020
Q2 | $72K | Sell |
6,560
-1,159
| -15% | -$12K | ﹤0.01% | 1111 |
|
|
2020
Q1 | $80K | Buy |
7,719
+7,469
| +2,988% | +$96.3K | ﹤0.01% | 1046 |
|
|
2019
Q4 | $4K | Buy |
250
+88
| +54% | +$1.45K | ﹤0.01% | 1446 |
|
|
2019
Q3 | $2K | Buy |
+162
| New | +$2.69K | ﹤0.01% | 1419 |
|
Other funds holding NXGN
Lazard Asset Management's NXGN Position: Q4 2023 in Review
Lazard Asset Management sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 9,176 shares — an estimated $217K sold.
Lazard Asset Management first reported a position in NXGN in Q3 2019 and held it in 16 quarters. The position peaked at $18.9M in Q3 2022. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.
- Lazard Asset Management reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Lazard Asset Management sold 9,176 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $217K.
- Lazard Asset Management first reported a position in NextGen Healthcare, Inc. Common Stock in Q3 2019 and held it in 16 quarters.
- Lazard Asset Management's NextGen Healthcare, Inc. Common Stock position peaked at $18.9M in Q3 2022.
- 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.
Based on Lazard Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.